Skip Navigation

Metastatic Breast Cancer Forum Highlights

  • from 2018

    Patients with metastatic breast cancer and their loved ones gathered October 20, 2018 for a full day of education, support, and companionship. Below are some highlights from the annual forum, directed by Nancy Lin, MD, and sponsored by Dana-Farber's Susan F. Smith Center for Women's Cancers and EMBRACE (Ending Metastatic Breast Cancer for Everyone).


  • Welcome and Overview

  • Nancy Lin, MD, and Eric P. Winer, MD, welcome attendees to the 2018 Metastatic Breast Cancer Forum and discuss research advances in the care and treatment of patients with metastatic breast cancer.


  • What's new in Research and Treatment for Estrogen Receptor Positive (ER+) Breast Cancer

  • Erica Mayer, MD, MPH, and Nikhil Wagle, MD, outline the research advances in the treatment of estrogen receptor positive (ER+) breast cancer.


  • What's new in Research and Treatment for Triple Negative Breast Cancer

  • Nancy Lin, MD, and Geoffrey Shapiro, MD, PhD, review treatment and research advances in the treatment of triple negative breast cancer.


  • What's new in Research and Treatment for HER2 Positive Breast Cancer

  • Heather Parsons, MD, MPH, and Ian Krop, MD, PhD, discuss the future of treating metastatic HER2+ breast cancer and how clinical trials help make progress in finding new therapies.


  • Panel on Symptom Management

  • The panelists Jennifer Ligibel, MD, James Tulsky, MD, Nancy Lin, MD, and Julie Salinger, MSW, LICSW, discuss symptoms management and answer questions from the audience.


  • Genetic Testing in Metastatic Breast Cancer

  • Huma Rana, MD, provides an overview of genetic testing and its practical applications.


  • Liquid Biopsies in Breast Cancer

  • Heather Parsons, MD, MPH, summarizes research advances in liquid biopsies and their potential for use in the diagnosis and treatment of breast cancer.


  • Clinical Trials 101

  • Sara Tolaney, MD, MPH, and Adrienne Waks, MD, provide an overview of clinical trials, including why they are necessary and how to participate in them.